{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0002-2059",
      "marketing_end_date": "20261013",
      "generic_name": "Pemetrexed disodium",
      "labeler_name": "Eli Lilly and Company",
      "active_ingredients": [
        {
          "name": "PEMETREXED DISODIUM HEPTAHYDRATE",
          "strength": "100 mg/4mL"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "0002-2059-71",
          "description": "200 VIAL in 1 BOX (0002-2059-71)  / 4 mL in 1 VIAL",
          "marketing_start_date": "15-JAN-08",
          "marketing_end_date": "13-OCT-26"
        }
      ],
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "d3208b13-30a1-4eb4-a280-882e6d9f344e",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20080115",
      "product_id": "0002-2059_d3208b13-30a1-4eb4-a280-882e6d9f344e",
      "brand_name_base": null
    }
  ]
}